Trading Ideas
Tesla stock in focus after SpaceX launch
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung discuss the market action for Tesla. …read more […]
President Trump pushes ‘law and order’ framework amid police brutality protests
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Rick Newman discuss President Trump’s response to the protests, and how it compares to past President’s responses in times of crisis.
…read more […]
Target, Lowe’s, among other major companies, respond to protests, call for change
The nation continues to grapple with civil unrest over the killing of George Floyd in police custody. Many leaders across retail, tech and banking are speaking out over the weekend and Monday morning as protests continue. Yahoo Finance’s Alexis Christoforous and Emily McCormick share the details. …read more […]
Facebook workers criticize Zuckerberg over Trump posts
Facebook employees are speaking out this weekend about Facebook CEO Mark Zuckerberg’s lack of movement to take down President Trump’s posts. Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Dan Howley break down the details. …read more […]
Zuckerberg Inaction on Trump’s Incendiary ‘Shooting’ Post Slammed by Facebook Employees
Click here to read the full article. Multiple Facebook employees publicly criticized CEO Mark Zuckerberg’s decision to not take down Donald Trump’s racially charged post suggesting Minneapolis rioters would be shot at.Zuckerberg, in a post Friday on Facebook, said while Trump’s message included a “troubling historical reference” — specifically, the phrase “when the looting starts, the shooting starts” — and while Zuckerberg personally disagreed with the president’s inflammatory rhetoric, Facebook decided to not remove it to “enable as much expression as possible.”Over the weekend, Facebook staffers took to Twitter to voice disagreement with Zuckerberg, with some lauding Twitter’s decision to …read more […]
Gilead Falls as Drug Has Only Small Benefit in Large Trial
(Bloomberg) — Gilead Sciences Inc.’s drug remdesivir showed only a limited benefit in a large trial of more moderate patients with Covid-19, a result that may shift perceptions of the therapy already cleared for use in severe cases of the disease.In the phase 3 trial, a group of moderately ill, hospitalized patients getting the drug for five days showed a modest improvement compared to those getting the standard of care, the company said in a statement. But another group getting the drug for 10 days didn’t show a statistically significant improvement, which is likely to raise questions about why a …read more […]
Protests spark concerns over spike in coronavirus cases
As protests against police brutality continue across the country, health officials are warning about the spread COVID-19. Yahoo Finance’s Alexis Christoforous and Brian Sozzi discuss with Bipartisan Policy Center Chief Medical Advisor Dr. Anand Parekh. …read more […]
Embraer open to new partnerships after Boeing deal collapses
Brazilian planemaker Embraer SA said on Monday that it expects to sign new strategic partnerships in the future, after Boeing Co abruptly canceled a deal in April to take over the company’s commercial jet division. Embraer Chief Executive Francisco Gomes Neto said it was still early to discuss such opportunities as the company is studying a new five-year plan. Reuters reported on Friday that China, Russia and India were circling Embraer and studying potential moves, although any talks would be preliminary. …read more […]
Hedge Funds Cashing Out Of General Dynamics Corporation (GD)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds’ and investors’ portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […] …read more […]
Here is What Hedge Funds Think About Qorvo Inc (QRVO)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […] …read more […]
OPEC+’s Talks for Short Extension to Cuts Leave Oil Steady
(Bloomberg) — The oil market took an initially neutral view on OPEC+ deliberations that could result in the producer group announcing a short extension to unprecedented output curbs.Futures in New York were little changed near $35 a barrel, though they held onto sharp gains from shortly before Friday’s close. The Organization of Petroleum Exporting Countries and its allies are considering bringing their next meeting forward to Thursday, where they will discuss prolonging production curbs by one to three months, according to a delegate. The existing agreement calls for the output cuts to ease from July.See also: Could OPEC+ Become a …read more […]
Zynga Snaps Up Peak For $1.8B In Its Largest Deal To Date; Shares Up 7%
Social game developer Zynga (ZNGA) has announced that it has entered into a definitive agreement to acquire Peak, one of the most globally successful mobile gaming companies, for $1.8 billion. Shares are rising 7% in Monday’s pre-market trading.Istanbul-based Peak brings two Forever Franchises to Zynga, Toon Blast and Toy Blast, that have consistently ranked in the top 10 and top 20 U.S. iPhone grossing games for over two years, respectively. Indeed, Peak is expected to grow Zynga’s average mobile DAUs by more than 60% while strengthening the company’s international audience.“Peak is one of the world’s best puzzle game makers and …read more […]
Eli Lilly Starts Dosing Patients In World’s First Covid-19 Antibody Trial
Eli Lilly (LLY) has today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19.Lilly scientists developed the antibody in just three months after AbCellera and the National Institute of Allergy and Infectious Diseases (NIAID) identified it from a blood sample taken from one of the first U.S. patients who recovered from COVID-19. LY-CoV555 is the first potential new medicine specifically designed …read more […]
